Pro Forma Information – Vitro Acquisition (Tables)

12 Months Ended

Dec. 31, 2015

Pro Forma Information – Vitro Acquisition

Schedule of pro-forma informations

	Year Ended December 31, 2015
	As						Pro Forma
	Reported		Acquisition		Financing		As Adjusted
	(restated(1))		Adjustments		Adjustments		(restated(1))
Net sales	$	6,156	$	574	$	—	$	6,730
Earnings from continuing operations attributable to the Company	$	139	$	75	$	(46)	$	168
Diluted earnings per share from continuing operations	$	0.85					$	1.04

(1) See Note 1 for restatement information.

	Year Ended December 31, 2014
	As						Pro Forma
	Reported		Acquisition		Financing		As Adjusted
	(restated(1))		Adjustments		Adjustments		(restated(1))
Net sales	$	6,784	$	858	$	—	$	7,642
Earnings from continuing operations attributable to the Company	$	187	$	70	$	(71)	$	186
Diluted earnings per share from continuing operations	$	1.13					$	1.12